Edwards Lifesciences is focused on technologies that treat structural heart disease and ill patients. The products and technologies provided by Co. are categorized into the several main areas, including: Transcatheter Aortic Valve Replacement, which is engaged in transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves; Transcatheter Mitral and Tricuspid Therapies, which is focused on the development of transcatheter heart valve repair and replacement technologies designed to treat mitral and tricuspid valve diseases; and Surgical Structural Heart, which is engaged in resilient surgical therapies. The EW stock yearly return is shown above.
The yearly return on the EW stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the EW annual return calculation with any dividends reinvested as applicable (on ex-dates).
|